Evaluation of Tenting the Schneiderian Membrane of the Maxillary Sinus Using Titanium Mesh.

Clinical, Radiographic and Histologic Evaluation of Tenting the Schneiderian Membrane Using Titanium Mesh for Maxillary Sinus Lift Procedure: A Randomized Controlled Study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07035236

Enrollment

Registered

2025-06-25

Start date

2025-07-15

Completion date

2026-12-01

Last updated

2026-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maxillary Sinus Floor Augmentation

Keywords

Tenting, Schneiderian membrane

Brief summary

Twenty posterior maxillary edentulous sites requiring open sinus augmentation for staged dental implant placement will be studied. Group I (study group) the maxillary sinus membrane will be elevated using titanium mesh fixed by bone screws. Group II (control group) will have stainless steel screws/pins placed bucco-palatally to maintain the elevated membrane and stabilize the formed blood clot. Platelet rich fibrin (PRF) will be placed at the site of elevated membrane in both groups.

Interventions

PROCEDUREmaxillary sinus lifting

The schneiderian membrane will be tented using titanium mesh.

PROCEDUREMaxillary sinus lifting

The Schneiderian membrane will be elevated using bone screws

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Inclusion criteria

* Adult male/female patients with age interval 18:60 years old. * Patients with one or more teeth requiring implant supported dental restoration in atrophic maxilla. * Alveolar bone height less than 5 mm at the defective site. * Good oral hygiene. * Patient's consensual agreement to be enrolled in the study.

Exclusion criteria

* Medically compromised patients with conditions contraindicating surgery (eg. uncontrolled diabetics, bisphosphonate intake, radio or chemotherapy). * Patients with active infection at or related to the site of surgery (eg. acute sinusitis). * Heavy smokers. * Patients not indicated for an implant supported restoration at the time of enrollement (eg. active/untreated periodontal disease). (Patients developing any medical condition that interferes with the outcomes after enrolment in the study will be excluded).

Design outcomes

Primary

Measure	Time frame	Description
Histological evaluation of gained bone quality	6 months	Using Hematoxin and Eosin stains
Radiographic Bone gain after maxillary sinus lift	6 months	Using Cone Beam CT

Countries

Egypt

Contacts

CONTACTHedra Sherif Michael

Hedra_sherif@dent.suez.edu.eg+201226182970

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 25, 2026